Latest News News

Apply Today: 2021 IIDR & DBCAD Seed Funding Grants

David Braley Centre for Antibiotic Discovery Seed Funding

About the Fund: Established in 2018, with the vision of helping eliminate the global threat of AMR through world-leading research in antimicrobial resistance and innovation in antibiotic discovery, the David Braley Centre for Antibiotic Discovery (DBCAD) is focused on addressing the global antibiotic crisis. The DBCAD is committed to providing seed funding for milestone-driven projects related to antimicrobial research and discovery that have the potential to leverage into powerful and significant grants. This funding provides an opportunity for members to make connections that otherwise would not have been possible and to amplify the impact of the work of the Centre.

Goal: The DBCAD will provide seed funding research support for a limited number of new team projects to generate preliminary data and provide evidence for collaboration that will enable member researchers to seek additional funding from other agencies. Projects that foster new collaborations across disciplines are encouraged.

Details: All members of the IIDR are eligible for support. Funds can be used to support trainees that are essential for the project, and operating funds. Special pricing for CMCB facilities will be in place to support this initiative. Travel expenses are ineligible. Maximal funding will be $50,000 and can be renewed once only, with evidence of acceptable momentum on the project. Projects NOT related to antibiotic discovery and antimicrobial resistance should be submitted to the IIDR call for proposals instead. A progress report for each project will be required regardless of intent to seek renewal. The Executive Committee will assess projects seeking renewal for progress towards milestones. Deadline for submission is February 19, 2021 and proposals will be externally peer-reviewed. An announcement of funded projects will be made March 19, 2021. Please submit your proposal to Lori Burrows via email at lori.burrows@mcmaster.ca.

CLICK HERE TO VIEW APPLICATION CRITERIA

______________________________________________________________________

Michael G. DeGroote Institute for Infectious Disease Research Seed Funding

About the Fund: Since its establishment in 2007, the IIDR has provided seed funding for new collaborations and high-risk projects. This funding provides an opportunity for members to make connections that otherwise would not have been possible and to amplify the impact of the work of the IIDR.

Goal: The IIDR will provide seed funding research support for a limited number of new projects to generate preliminary data and provide evidence for collaboration that will enable member researchers to seek additional funding from other agencies. Projects should be focused around the overarching themes of anti-infective innovation, diagnostics, and laboratory/clinical collaborations. New projects that foster collaborations across disciplines are encouraged.

Details: All members of the IIDR are eligible for support. Funds can be used to support trainees that are essential for the project, and operating funds. Special pricing for CMCB facilities will be in place to support this initiative. Travel expenses are ineligible. Maximal funding will be $50,000 and can be renewed once only, with evidence of acceptable momentum on the project. Projects related to antibiotic discovery and antimicrobial resistance should be submitted to the David Braley Centre for Antibiotic Discovery call for proposals instead. A progress report for each project will be required, regardless of intent to request renewal. The Executive Committee will assess projects seeking renewal for progress towards milestones. Deadline for submission is February 19, 2021 and applications will be externally peer-reviewed. An announcement of funded projects will be made March 19, 2021. Please submit your proposal to Lori Burrows via email lori.burrows@mcmaster.ca.

CLICK HERE TO VIEW APPLICATION CRITERIA

Author:

Blake Dillon